Autoantibodies as prognosticators of treatment outcome in cancerous diseases: learning from immune-check point inhibitors

Vasileios Papadopoulos, Eleni Patrikiou, Christos Liaskos, Christina Tsigalou, Dimitrios P. Bogdanos